nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenelzine—CYP3A4—Thiotepa—urinary bladder cancer	0.0511	0.221	CbGbCtD
Phenelzine—CYP2E1—Etoposide—urinary bladder cancer	0.0457	0.198	CbGbCtD
Phenelzine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0409	0.177	CbGbCtD
Phenelzine—CYP3A5—Etoposide—urinary bladder cancer	0.0355	0.154	CbGbCtD
Phenelzine—CYP2C8—Etoposide—urinary bladder cancer	0.0342	0.148	CbGbCtD
Phenelzine—CYP3A4—Etoposide—urinary bladder cancer	0.0139	0.06	CbGbCtD
Phenelzine—GPT—seminal vesicle—urinary bladder cancer	0.0137	0.0548	CbGeAlD
Phenelzine—GPT2—prostate gland—urinary bladder cancer	0.0124	0.0495	CbGeAlD
Phenelzine—GPT—renal system—urinary bladder cancer	0.0111	0.0441	CbGeAlD
Phenelzine—AOC3—prostate gland—urinary bladder cancer	0.0108	0.043	CbGeAlD
Phenelzine—CYP2C19—urine—urinary bladder cancer	0.0108	0.0429	CbGeAlD
Phenelzine—GPT2—seminal vesicle—urinary bladder cancer	0.0105	0.0419	CbGeAlD
Phenelzine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00945	0.0409	CbGbCtD
Phenelzine—AOC3—seminal vesicle—urinary bladder cancer	0.00911	0.0364	CbGeAlD
Phenelzine—ABAT—prostate gland—urinary bladder cancer	0.0091	0.0363	CbGeAlD
Phenelzine—GPT2—renal system—urinary bladder cancer	0.00845	0.0337	CbGeAlD
Phenelzine—GPT—vagina—urinary bladder cancer	0.008	0.032	CbGeAlD
Phenelzine—CYP2E1—urine—urinary bladder cancer	0.0079	0.0315	CbGeAlD
Phenelzine—AOC3—smooth muscle tissue—urinary bladder cancer	0.00762	0.0304	CbGeAlD
Phenelzine—AOC3—renal system—urinary bladder cancer	0.00734	0.0293	CbGeAlD
Phenelzine—AOC3—urethra—urinary bladder cancer	0.00721	0.0288	CbGeAlD
Phenelzine—GPT2—female reproductive system—urinary bladder cancer	0.00677	0.027	CbGeAlD
Phenelzine—CYP3A4—urine—urinary bladder cancer	0.00636	0.0254	CbGeAlD
Phenelzine—ABAT—renal system—urinary bladder cancer	0.0062	0.0248	CbGeAlD
Phenelzine—GPT2—vagina—urinary bladder cancer	0.00612	0.0244	CbGeAlD
Phenelzine—AOC3—female reproductive system—urinary bladder cancer	0.00588	0.0235	CbGeAlD
Phenelzine—AOC3—vagina—urinary bladder cancer	0.00532	0.0212	CbGeAlD
Phenelzine—ABAT—vagina—urinary bladder cancer	0.00449	0.0179	CbGeAlD
Phenelzine—MAOB—prostate gland—urinary bladder cancer	0.00443	0.0177	CbGeAlD
Phenelzine—GPT2—lymph node—urinary bladder cancer	0.00396	0.0158	CbGeAlD
Phenelzine—MAOA—prostate gland—urinary bladder cancer	0.00378	0.0151	CbGeAlD
Phenelzine—MAOB—seminal vesicle—urinary bladder cancer	0.00375	0.015	CbGeAlD
Phenelzine—AOC3—lymph node—urinary bladder cancer	0.00344	0.0137	CbGeAlD
Phenelzine—MAOA—seminal vesicle—urinary bladder cancer	0.0032	0.0128	CbGeAlD
Phenelzine—CYP3A5—prostate gland—urinary bladder cancer	0.00304	0.0121	CbGeAlD
Phenelzine—MAOB—renal system—urinary bladder cancer	0.00302	0.0121	CbGeAlD
Phenelzine—MAOB—urethra—urinary bladder cancer	0.00296	0.0118	CbGeAlD
Phenelzine—ABAT—lymph node—urinary bladder cancer	0.00291	0.0116	CbGeAlD
Phenelzine—CYP2E1—prostate gland—urinary bladder cancer	0.00284	0.0113	CbGeAlD
Phenelzine—MAOA—renal system—urinary bladder cancer	0.00257	0.0103	CbGeAlD
Phenelzine—MAOA—urethra—urinary bladder cancer	0.00253	0.0101	CbGeAlD
Phenelzine—MAOB—female reproductive system—urinary bladder cancer	0.00242	0.00965	CbGeAlD
Phenelzine—CYP2E1—seminal vesicle—urinary bladder cancer	0.0024	0.00958	CbGeAlD
Phenelzine—CYP2C8—renal system—urinary bladder cancer	0.0023	0.00917	CbGeAlD
Phenelzine—MAOB—vagina—urinary bladder cancer	0.00219	0.00873	CbGeAlD
Phenelzine—CYP3A5—renal system—urinary bladder cancer	0.00207	0.00827	CbGeAlD
Phenelzine—MAOA—female reproductive system—urinary bladder cancer	0.00206	0.00823	CbGeAlD
Phenelzine—Pruritus—Valrubicin—urinary bladder cancer	0.00199	0.00828	CcSEcCtD
Phenelzine—Euphoric mood—Fluorouracil—urinary bladder cancer	0.00195	0.00808	CcSEcCtD
Phenelzine—Oedema—Mitomycin—urinary bladder cancer	0.00194	0.00806	CcSEcCtD
Phenelzine—Hypernatraemia—Doxorubicin—urinary bladder cancer	0.00194	0.00805	CcSEcCtD
Phenelzine—CYP2E1—renal system—urinary bladder cancer	0.00193	0.00772	CbGeAlD
Phenelzine—Shock—Mitomycin—urinary bladder cancer	0.00191	0.00793	CcSEcCtD
Phenelzine—CYP2C19—vagina—urinary bladder cancer	0.00191	0.00761	CbGeAlD
Phenelzine—CYP2E1—urethra—urinary bladder cancer	0.0019	0.00758	CbGeAlD
Phenelzine—Urinary retention—Thiotepa—urinary bladder cancer	0.00189	0.00784	CcSEcCtD
Phenelzine—Ataxia—Thiotepa—urinary bladder cancer	0.00187	0.00776	CcSEcCtD
Phenelzine—MAOA—vagina—urinary bladder cancer	0.00187	0.00745	CbGeAlD
Phenelzine—Dizziness—Valrubicin—urinary bladder cancer	0.00186	0.00774	CcSEcCtD
Phenelzine—CYP2C8—female reproductive system—urinary bladder cancer	0.00184	0.00734	CbGeAlD
Phenelzine—Vomiting—Valrubicin—urinary bladder cancer	0.00179	0.00744	CcSEcCtD
Phenelzine—Rash—Valrubicin—urinary bladder cancer	0.00178	0.00738	CcSEcCtD
Phenelzine—Dermatitis—Valrubicin—urinary bladder cancer	0.00178	0.00737	CcSEcCtD
Phenelzine—Headache—Valrubicin—urinary bladder cancer	0.00177	0.00733	CcSEcCtD
Phenelzine—Somnolence—Mitomycin—urinary bladder cancer	0.00173	0.00717	CcSEcCtD
Phenelzine—Nausea—Valrubicin—urinary bladder cancer	0.00167	0.00695	CcSEcCtD
Phenelzine—Fatigue—Mitomycin—urinary bladder cancer	0.00167	0.00695	CcSEcCtD
Phenelzine—CYP2C8—vagina—urinary bladder cancer	0.00166	0.00664	CbGeAlD
Phenelzine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0016	0.00664	CcSEcCtD
Phenelzine—Weight increased—Thiotepa—urinary bladder cancer	0.00156	0.00649	CcSEcCtD
Phenelzine—CYP3A4—renal system—urinary bladder cancer	0.00156	0.00621	CbGeAlD
Phenelzine—CYP2E1—female reproductive system—urinary bladder cancer	0.00155	0.00618	CbGeAlD
Phenelzine—Ataxia—Fluorouracil—urinary bladder cancer	0.00155	0.00642	CcSEcCtD
Phenelzine—Nystagmus—Epirubicin—urinary bladder cancer	0.00154	0.00641	CcSEcCtD
Phenelzine—Body temperature increased—Mitomycin—urinary bladder cancer	0.00154	0.00637	CcSEcCtD
Phenelzine—CYP3A5—vagina—urinary bladder cancer	0.0015	0.00599	CbGeAlD
Phenelzine—Jaundice—Thiotepa—urinary bladder cancer	0.00149	0.0062	CcSEcCtD
Phenelzine—Nystagmus—Doxorubicin—urinary bladder cancer	0.00143	0.00593	CcSEcCtD
Phenelzine—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.00142	0.00591	CcSEcCtD
Phenelzine—MAOB—lymph node—urinary bladder cancer	0.00141	0.00565	CbGeAlD
Phenelzine—Asthenia—Mitomycin—urinary bladder cancer	0.00139	0.00578	CcSEcCtD
Phenelzine—Liver injury—Epirubicin—urinary bladder cancer	0.00131	0.00544	CcSEcCtD
Phenelzine—Dizziness—Mitomycin—urinary bladder cancer	0.00128	0.00533	CcSEcCtD
Phenelzine—Delirium—Epirubicin—urinary bladder cancer	0.00128	0.00532	CcSEcCtD
Phenelzine—CYP3A4—female reproductive system—urinary bladder cancer	0.00125	0.00497	CbGeAlD
Phenelzine—Sweating—Gemcitabine—urinary bladder cancer	0.00124	0.00513	CcSEcCtD
Phenelzine—Vomiting—Mitomycin—urinary bladder cancer	0.00124	0.00513	CcSEcCtD
Phenelzine—Rash—Mitomycin—urinary bladder cancer	0.00122	0.00508	CcSEcCtD
Phenelzine—Dermatitis—Mitomycin—urinary bladder cancer	0.00122	0.00508	CcSEcCtD
Phenelzine—Headache—Mitomycin—urinary bladder cancer	0.00122	0.00505	CcSEcCtD
Phenelzine—Liver injury—Doxorubicin—urinary bladder cancer	0.00121	0.00503	CcSEcCtD
Phenelzine—MAOA—lymph node—urinary bladder cancer	0.00121	0.00482	CbGeAlD
Phenelzine—Delirium—Doxorubicin—urinary bladder cancer	0.00119	0.00492	CcSEcCtD
Phenelzine—Nervousness—Thiotepa—urinary bladder cancer	0.00116	0.00483	CcSEcCtD
Phenelzine—Nausea—Mitomycin—urinary bladder cancer	0.00115	0.00479	CcSEcCtD
Phenelzine—Vision blurred—Thiotepa—urinary bladder cancer	0.00113	0.00468	CcSEcCtD
Phenelzine—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.0011	0.00458	CcSEcCtD
Phenelzine—Agitation—Thiotepa—urinary bladder cancer	0.0011	0.00457	CcSEcCtD
Phenelzine—Coma—Methotrexate—urinary bladder cancer	0.00108	0.00447	CcSEcCtD
Phenelzine—Jaundice—Etoposide—urinary bladder cancer	0.00107	0.00445	CcSEcCtD
Phenelzine—Leukopenia—Thiotepa—urinary bladder cancer	0.00107	0.00445	CcSEcCtD
Phenelzine—Convulsion—Thiotepa—urinary bladder cancer	0.00104	0.0043	CcSEcCtD
Phenelzine—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.00102	0.00423	CcSEcCtD
Phenelzine—Anxiety—Thiotepa—urinary bladder cancer	0.00102	0.00421	CcSEcCtD
Phenelzine—Coma—Epirubicin—urinary bladder cancer	0.00101	0.00418	CcSEcCtD
Phenelzine—Hypertonia—Epirubicin—urinary bladder cancer	0.000966	0.00401	CcSEcCtD
Phenelzine—Tachycardia—Thiotepa—urinary bladder cancer	0.000953	0.00396	CcSEcCtD
Phenelzine—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000934	0.00388	CcSEcCtD
Phenelzine—Vision blurred—Fluorouracil—urinary bladder cancer	0.000933	0.00387	CcSEcCtD
Phenelzine—Coma—Doxorubicin—urinary bladder cancer	0.000932	0.00387	CcSEcCtD
Phenelzine—Malaise—Gemcitabine—urinary bladder cancer	0.000908	0.00377	CcSEcCtD
Phenelzine—Leukopenia—Gemcitabine—urinary bladder cancer	0.000901	0.00374	CcSEcCtD
Phenelzine—Hypertonia—Doxorubicin—urinary bladder cancer	0.000894	0.00371	CcSEcCtD
Phenelzine—Leukopenia—Fluorouracil—urinary bladder cancer	0.000886	0.00368	CcSEcCtD
Phenelzine—Vision blurred—Cisplatin—urinary bladder cancer	0.000885	0.00367	CcSEcCtD
Phenelzine—Tremor—Cisplatin—urinary bladder cancer	0.000879	0.00365	CcSEcCtD
Phenelzine—Paraesthesia—Thiotepa—urinary bladder cancer	0.000877	0.00364	CcSEcCtD
Phenelzine—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000871	0.00361	CcSEcCtD
Phenelzine—Somnolence—Thiotepa—urinary bladder cancer	0.000868	0.0036	CcSEcCtD
Phenelzine—Dyspepsia—Thiotepa—urinary bladder cancer	0.00086	0.00357	CcSEcCtD
Phenelzine—Convulsion—Fluorouracil—urinary bladder cancer	0.000858	0.00356	CcSEcCtD
Phenelzine—Discomfort—Gemcitabine—urinary bladder cancer	0.000847	0.00352	CcSEcCtD
Phenelzine—Malaise—Cisplatin—urinary bladder cancer	0.000846	0.00351	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000843	0.0035	CcSEcCtD
Phenelzine—Fatigue—Thiotepa—urinary bladder cancer	0.000842	0.0035	CcSEcCtD
Phenelzine—Leukopenia—Cisplatin—urinary bladder cancer	0.00084	0.00349	CcSEcCtD
Phenelzine—Constipation—Thiotepa—urinary bladder cancer	0.000835	0.00347	CcSEcCtD
Phenelzine—Discomfort—Fluorouracil—urinary bladder cancer	0.000833	0.00346	CcSEcCtD
Phenelzine—Oedema—Gemcitabine—urinary bladder cancer	0.000822	0.00341	CcSEcCtD
Phenelzine—Convulsion—Cisplatin—urinary bladder cancer	0.000813	0.00337	CcSEcCtD
Phenelzine—Oedema—Fluorouracil—urinary bladder cancer	0.000808	0.00335	CcSEcCtD
Phenelzine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000805	0.00334	CcSEcCtD
Phenelzine—Ataxia—Methotrexate—urinary bladder cancer	0.000804	0.00334	CcSEcCtD
Phenelzine—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000798	0.00331	CcSEcCtD
Phenelzine—Anxiety—Cisplatin—urinary bladder cancer	0.000796	0.0033	CcSEcCtD
Phenelzine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000794	0.0033	CcSEcCtD
Phenelzine—Discomfort—Cisplatin—urinary bladder cancer	0.000789	0.00328	CcSEcCtD
Phenelzine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000789	0.00327	CcSEcCtD
Phenelzine—Malaise—Etoposide—urinary bladder cancer	0.000775	0.00322	CcSEcCtD
Phenelzine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000772	0.00321	CcSEcCtD
Phenelzine—Leukopenia—Etoposide—urinary bladder cancer	0.00077	0.00319	CcSEcCtD
Phenelzine—Oedema—Cisplatin—urinary bladder cancer	0.000766	0.00318	CcSEcCtD
Phenelzine—Ataxia—Epirubicin—urinary bladder cancer	0.000753	0.00312	CcSEcCtD
Phenelzine—Tachycardia—Cisplatin—urinary bladder cancer	0.000748	0.0031	CcSEcCtD
Phenelzine—Convulsion—Etoposide—urinary bladder cancer	0.000745	0.00309	CcSEcCtD
Phenelzine—Insomnia—Gemcitabine—urinary bladder cancer	0.000743	0.00308	CcSEcCtD
Phenelzine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00074	0.00307	CcSEcCtD
Phenelzine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000738	0.00306	CcSEcCtD
Phenelzine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.000731	0.00303	CcSEcCtD
Phenelzine—Insomnia—Fluorouracil—urinary bladder cancer	0.000731	0.00303	CcSEcCtD
Phenelzine—Somnolence—Gemcitabine—urinary bladder cancer	0.000731	0.00303	CcSEcCtD
Phenelzine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000726	0.00301	CcSEcCtD
Phenelzine—Discomfort—Etoposide—urinary bladder cancer	0.000723	0.003	CcSEcCtD
Phenelzine—Somnolence—Fluorouracil—urinary bladder cancer	0.000718	0.00298	CcSEcCtD
Phenelzine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000711	0.00295	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000709	0.00294	CcSEcCtD
Phenelzine—Fatigue—Gemcitabine—urinary bladder cancer	0.000709	0.00294	CcSEcCtD
Phenelzine—Constipation—Gemcitabine—urinary bladder cancer	0.000703	0.00292	CcSEcCtD
Phenelzine—Asthenia—Thiotepa—urinary bladder cancer	0.000701	0.00291	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000698	0.0029	CcSEcCtD
Phenelzine—Ataxia—Doxorubicin—urinary bladder cancer	0.000696	0.00289	CcSEcCtD
Phenelzine—Pruritus—Thiotepa—urinary bladder cancer	0.000691	0.00287	CcSEcCtD
Phenelzine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000688	0.00285	CcSEcCtD
Phenelzine—Tachycardia—Etoposide—urinary bladder cancer	0.000685	0.00284	CcSEcCtD
Phenelzine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000681	0.00283	CcSEcCtD
Phenelzine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000678	0.00282	CcSEcCtD
Phenelzine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000677	0.00281	CcSEcCtD
Phenelzine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000676	0.00281	CcSEcCtD
Phenelzine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000666	0.00276	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000661	0.00274	CcSEcCtD
Phenelzine—Drowsiness—Methotrexate—urinary bladder cancer	0.000659	0.00274	CcSEcCtD
Phenelzine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00065	0.0027	CcSEcCtD
Phenelzine—Dizziness—Thiotepa—urinary bladder cancer	0.000646	0.00268	CcSEcCtD
Phenelzine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000639	0.00265	CcSEcCtD
Phenelzine—Sweating—Methotrexate—urinary bladder cancer	0.000632	0.00262	CcSEcCtD
Phenelzine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000631	0.00262	CcSEcCtD
Phenelzine—Paraesthesia—Etoposide—urinary bladder cancer	0.00063	0.00262	CcSEcCtD
Phenelzine—Weight increased—Epirubicin—urinary bladder cancer	0.00063	0.00261	CcSEcCtD
Phenelzine—Somnolence—Etoposide—urinary bladder cancer	0.000624	0.00259	CcSEcCtD
Phenelzine—Vomiting—Thiotepa—urinary bladder cancer	0.000621	0.00258	CcSEcCtD
Phenelzine—Drowsiness—Epirubicin—urinary bladder cancer	0.000617	0.00256	CcSEcCtD
Phenelzine—Rash—Thiotepa—urinary bladder cancer	0.000616	0.00256	CcSEcCtD
Phenelzine—Dermatitis—Thiotepa—urinary bladder cancer	0.000615	0.00255	CcSEcCtD
Phenelzine—Headache—Thiotepa—urinary bladder cancer	0.000612	0.00254	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000606	0.00251	CcSEcCtD
Phenelzine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000606	0.00251	CcSEcCtD
Phenelzine—Fatigue—Etoposide—urinary bladder cancer	0.000605	0.00251	CcSEcCtD
Phenelzine—Jaundice—Epirubicin—urinary bladder cancer	0.000601	0.0025	CcSEcCtD
Phenelzine—Constipation—Etoposide—urinary bladder cancer	0.0006	0.00249	CcSEcCtD
Phenelzine—Sweating—Epirubicin—urinary bladder cancer	0.000591	0.00245	CcSEcCtD
Phenelzine—Asthenia—Gemcitabine—urinary bladder cancer	0.00059	0.00245	CcSEcCtD
Phenelzine—Weight increased—Doxorubicin—urinary bladder cancer	0.000582	0.00242	CcSEcCtD
Phenelzine—Pruritus—Gemcitabine—urinary bladder cancer	0.000581	0.00241	CcSEcCtD
Phenelzine—Nausea—Thiotepa—urinary bladder cancer	0.00058	0.00241	CcSEcCtD
Phenelzine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000578	0.0024	CcSEcCtD
Phenelzine—Pruritus—Fluorouracil—urinary bladder cancer	0.000572	0.00237	CcSEcCtD
Phenelzine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000571	0.00237	CcSEcCtD
Phenelzine—Jaundice—Doxorubicin—urinary bladder cancer	0.000556	0.00231	CcSEcCtD
Phenelzine—Body temperature increased—Etoposide—urinary bladder cancer	0.000555	0.0023	CcSEcCtD
Phenelzine—Asthenia—Cisplatin—urinary bladder cancer	0.00055	0.00228	CcSEcCtD
Phenelzine—Sweating—Doxorubicin—urinary bladder cancer	0.000547	0.00227	CcSEcCtD
Phenelzine—Dizziness—Fluorouracil—urinary bladder cancer	0.000534	0.00222	CcSEcCtD
Phenelzine—Vomiting—Gemcitabine—urinary bladder cancer	0.000523	0.00217	CcSEcCtD
Phenelzine—Rash—Gemcitabine—urinary bladder cancer	0.000518	0.00215	CcSEcCtD
Phenelzine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000518	0.00215	CcSEcCtD
Phenelzine—Headache—Gemcitabine—urinary bladder cancer	0.000515	0.00214	CcSEcCtD
Phenelzine—Vomiting—Fluorouracil—urinary bladder cancer	0.000514	0.00213	CcSEcCtD
Phenelzine—Rash—Fluorouracil—urinary bladder cancer	0.000509	0.00211	CcSEcCtD
Phenelzine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000509	0.00211	CcSEcCtD
Phenelzine—Headache—Fluorouracil—urinary bladder cancer	0.000506	0.0021	CcSEcCtD
Phenelzine—Asthenia—Etoposide—urinary bladder cancer	0.000503	0.00209	CcSEcCtD
Phenelzine—Pruritus—Etoposide—urinary bladder cancer	0.000496	0.00206	CcSEcCtD
Phenelzine—Nausea—Gemcitabine—urinary bladder cancer	0.000488	0.00203	CcSEcCtD
Phenelzine—Vomiting—Cisplatin—urinary bladder cancer	0.000487	0.00202	CcSEcCtD
Phenelzine—Vision blurred—Methotrexate—urinary bladder cancer	0.000485	0.00201	CcSEcCtD
Phenelzine—Rash—Cisplatin—urinary bladder cancer	0.000483	0.002	CcSEcCtD
Phenelzine—Dermatitis—Cisplatin—urinary bladder cancer	0.000483	0.002	CcSEcCtD
Phenelzine—Nausea—Fluorouracil—urinary bladder cancer	0.00048	0.00199	CcSEcCtD
Phenelzine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000478	0.00198	CcSEcCtD
Phenelzine—Nervousness—Epirubicin—urinary bladder cancer	0.000468	0.00194	CcSEcCtD
Phenelzine—Malaise—Methotrexate—urinary bladder cancer	0.000464	0.00193	CcSEcCtD
Phenelzine—Dizziness—Etoposide—urinary bladder cancer	0.000464	0.00193	CcSEcCtD
Phenelzine—Leukopenia—Methotrexate—urinary bladder cancer	0.000461	0.00191	CcSEcCtD
Phenelzine—Nausea—Cisplatin—urinary bladder cancer	0.000455	0.00189	CcSEcCtD
Phenelzine—Vision blurred—Epirubicin—urinary bladder cancer	0.000454	0.00189	CcSEcCtD
Phenelzine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000447	0.00186	CcSEcCtD
Phenelzine—Convulsion—Methotrexate—urinary bladder cancer	0.000446	0.00185	CcSEcCtD
Phenelzine—Vomiting—Etoposide—urinary bladder cancer	0.000446	0.00185	CcSEcCtD
Phenelzine—Agitation—Epirubicin—urinary bladder cancer	0.000443	0.00184	CcSEcCtD
Phenelzine—Rash—Etoposide—urinary bladder cancer	0.000442	0.00184	CcSEcCtD
Phenelzine—Dermatitis—Etoposide—urinary bladder cancer	0.000442	0.00183	CcSEcCtD
Phenelzine—Headache—Etoposide—urinary bladder cancer	0.00044	0.00182	CcSEcCtD
Phenelzine—Malaise—Epirubicin—urinary bladder cancer	0.000435	0.0018	CcSEcCtD
Phenelzine—Discomfort—Methotrexate—urinary bladder cancer	0.000433	0.0018	CcSEcCtD
Phenelzine—Nervousness—Doxorubicin—urinary bladder cancer	0.000433	0.0018	CcSEcCtD
Phenelzine—Leukopenia—Epirubicin—urinary bladder cancer	0.000431	0.00179	CcSEcCtD
Phenelzine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00042	0.00174	CcSEcCtD
Phenelzine—Convulsion—Epirubicin—urinary bladder cancer	0.000418	0.00173	CcSEcCtD
Phenelzine—Nausea—Etoposide—urinary bladder cancer	0.000417	0.00173	CcSEcCtD
Phenelzine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000414	0.00172	CcSEcCtD
Phenelzine—Agitation—Doxorubicin—urinary bladder cancer	0.00041	0.0017	CcSEcCtD
Phenelzine—Anxiety—Epirubicin—urinary bladder cancer	0.000409	0.0017	CcSEcCtD
Phenelzine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000406	0.00169	CcSEcCtD
Phenelzine—Discomfort—Epirubicin—urinary bladder cancer	0.000405	0.00168	CcSEcCtD
Phenelzine—Malaise—Doxorubicin—urinary bladder cancer	0.000402	0.00167	CcSEcCtD
Phenelzine—Dry mouth—Epirubicin—urinary bladder cancer	0.000401	0.00167	CcSEcCtD
Phenelzine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000399	0.00166	CcSEcCtD
Phenelzine—Oedema—Epirubicin—urinary bladder cancer	0.000393	0.00163	CcSEcCtD
Phenelzine—Shock—Epirubicin—urinary bladder cancer	0.000387	0.00161	CcSEcCtD
Phenelzine—Convulsion—Doxorubicin—urinary bladder cancer	0.000386	0.0016	CcSEcCtD
Phenelzine—Tachycardia—Epirubicin—urinary bladder cancer	0.000384	0.00159	CcSEcCtD
Phenelzine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00038	0.00158	CcSEcCtD
Phenelzine—Insomnia—Methotrexate—urinary bladder cancer	0.00038	0.00158	CcSEcCtD
Phenelzine—Anxiety—Doxorubicin—urinary bladder cancer	0.000378	0.00157	CcSEcCtD
Phenelzine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000377	0.00157	CcSEcCtD
Phenelzine—Discomfort—Doxorubicin—urinary bladder cancer	0.000375	0.00156	CcSEcCtD
Phenelzine—Somnolence—Methotrexate—urinary bladder cancer	0.000374	0.00155	CcSEcCtD
Phenelzine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000371	0.00154	CcSEcCtD
Phenelzine—Dyspepsia—Methotrexate—urinary bladder cancer	0.00037	0.00154	CcSEcCtD
Phenelzine—Oedema—Doxorubicin—urinary bladder cancer	0.000364	0.00151	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000363	0.00151	CcSEcCtD
Phenelzine—Fatigue—Methotrexate—urinary bladder cancer	0.000362	0.0015	CcSEcCtD
Phenelzine—Shock—Doxorubicin—urinary bladder cancer	0.000358	0.00149	CcSEcCtD
Phenelzine—Insomnia—Epirubicin—urinary bladder cancer	0.000356	0.00148	CcSEcCtD
Phenelzine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000355	0.00147	CcSEcCtD
Phenelzine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000353	0.00147	CcSEcCtD
Phenelzine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000352	0.00146	CcSEcCtD
Phenelzine—Somnolence—Epirubicin—urinary bladder cancer	0.00035	0.00145	CcSEcCtD
Phenelzine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000346	0.00144	CcSEcCtD
Phenelzine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000346	0.00144	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00034	0.00141	CcSEcCtD
Phenelzine—Fatigue—Epirubicin—urinary bladder cancer	0.000339	0.00141	CcSEcCtD
Phenelzine—Constipation—Epirubicin—urinary bladder cancer	0.000336	0.0014	CcSEcCtD
Phenelzine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000332	0.00138	CcSEcCtD
Phenelzine—Insomnia—Doxorubicin—urinary bladder cancer	0.000329	0.00137	CcSEcCtD
Phenelzine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000327	0.00136	CcSEcCtD
Phenelzine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000324	0.00135	CcSEcCtD
Phenelzine—Somnolence—Doxorubicin—urinary bladder cancer	0.000324	0.00134	CcSEcCtD
Phenelzine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00032	0.00133	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000314	0.0013	CcSEcCtD
Phenelzine—Fatigue—Doxorubicin—urinary bladder cancer	0.000314	0.0013	CcSEcCtD
Phenelzine—Constipation—Doxorubicin—urinary bladder cancer	0.000311	0.00129	CcSEcCtD
Phenelzine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000311	0.00129	CcSEcCtD
Phenelzine—Asthenia—Methotrexate—urinary bladder cancer	0.000302	0.00125	CcSEcCtD
Phenelzine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.0003	0.00124	CcSEcCtD
Phenelzine—Pruritus—Methotrexate—urinary bladder cancer	0.000297	0.00123	CcSEcCtD
Phenelzine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000288	0.00119	CcSEcCtD
Phenelzine—Asthenia—Epirubicin—urinary bladder cancer	0.000282	0.00117	CcSEcCtD
Phenelzine—Pruritus—Epirubicin—urinary bladder cancer	0.000278	0.00116	CcSEcCtD
Phenelzine—Dizziness—Methotrexate—urinary bladder cancer	0.000278	0.00115	CcSEcCtD
Phenelzine—Vomiting—Methotrexate—urinary bladder cancer	0.000267	0.00111	CcSEcCtD
Phenelzine—Rash—Methotrexate—urinary bladder cancer	0.000265	0.0011	CcSEcCtD
Phenelzine—Dermatitis—Methotrexate—urinary bladder cancer	0.000265	0.0011	CcSEcCtD
Phenelzine—Headache—Methotrexate—urinary bladder cancer	0.000263	0.00109	CcSEcCtD
Phenelzine—Asthenia—Doxorubicin—urinary bladder cancer	0.000261	0.00108	CcSEcCtD
Phenelzine—Dizziness—Epirubicin—urinary bladder cancer	0.00026	0.00108	CcSEcCtD
Phenelzine—Pruritus—Doxorubicin—urinary bladder cancer	0.000258	0.00107	CcSEcCtD
Phenelzine—Vomiting—Epirubicin—urinary bladder cancer	0.00025	0.00104	CcSEcCtD
Phenelzine—Nausea—Methotrexate—urinary bladder cancer	0.00025	0.00104	CcSEcCtD
Phenelzine—Rash—Epirubicin—urinary bladder cancer	0.000248	0.00103	CcSEcCtD
Phenelzine—Dermatitis—Epirubicin—urinary bladder cancer	0.000248	0.00103	CcSEcCtD
Phenelzine—Headache—Epirubicin—urinary bladder cancer	0.000246	0.00102	CcSEcCtD
Phenelzine—Dizziness—Doxorubicin—urinary bladder cancer	0.000241	0.000999	CcSEcCtD
Phenelzine—Nausea—Epirubicin—urinary bladder cancer	0.000234	0.00097	CcSEcCtD
Phenelzine—Vomiting—Doxorubicin—urinary bladder cancer	0.000231	0.00096	CcSEcCtD
Phenelzine—Rash—Doxorubicin—urinary bladder cancer	0.000229	0.000952	CcSEcCtD
Phenelzine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000229	0.000952	CcSEcCtD
Phenelzine—Headache—Doxorubicin—urinary bladder cancer	0.000228	0.000946	CcSEcCtD
Phenelzine—Nausea—Doxorubicin—urinary bladder cancer	0.000216	0.000897	CcSEcCtD
Phenelzine—GPT—Metabolism—CREBBP—urinary bladder cancer	0.00017	0.000613	CbGpPWpGaD
Phenelzine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00017	0.000613	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	0.000169	0.000609	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—GSTT1—urinary bladder cancer	0.000169	0.000609	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000166	0.000597	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—NAT2—urinary bladder cancer	0.000165	0.000595	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	0.00016	0.000577	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—NAT1—urinary bladder cancer	0.00016	0.000577	CbGpPWpGaD
Phenelzine—CYP2C8—Biological oxidations—GSTM1—urinary bladder cancer	0.000159	0.000572	CbGpPWpGaD
Phenelzine—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000157	0.000564	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—CYP4B1—urinary bladder cancer	0.000156	0.000561	CbGpPWpGaD
Phenelzine—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000154	0.000556	CbGpPWpGaD
Phenelzine—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000152	0.000548	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000152	0.000547	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—PTEN—urinary bladder cancer	0.000149	0.000537	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—SLC19A1—urinary bladder cancer	0.000147	0.00053	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	0.000147	0.000528	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—PRSS3—urinary bladder cancer	0.000143	0.000517	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—RRM2—urinary bladder cancer	0.000143	0.000514	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—EP300—urinary bladder cancer	0.000142	0.000513	CbGpPWpGaD
Phenelzine—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000142	0.000511	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—NQO1—urinary bladder cancer	0.000141	0.000506	CbGpPWpGaD
Phenelzine—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00014	0.000503	CbGpPWpGaD
Phenelzine—GPT—Metabolism—PTGS2—urinary bladder cancer	0.00014	0.000502	CbGpPWpGaD
Phenelzine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000138	0.000497	CbGpPWpGaD
Phenelzine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000134	0.000482	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—ENO2—urinary bladder cancer	0.000132	0.000476	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—HPGDS—urinary bladder cancer	0.000132	0.000476	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	0.000132	0.000475	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—GSTT1—urinary bladder cancer	0.000128	0.000461	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	0.000125	0.000449	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000123	0.000444	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	0.000123	0.000441	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.000122	0.00044	CbGpPWpGaD
Phenelzine—GPT—Metabolism—PTEN—urinary bladder cancer	0.000122	0.000438	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	0.000122	0.000438	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—GSTP1—urinary bladder cancer	0.000117	0.000422	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	0.000116	0.000418	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—NAT1—urinary bladder cancer	0.000116	0.000418	CbGpPWpGaD
Phenelzine—GPT—Metabolism—EP300—urinary bladder cancer	0.000116	0.000418	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000116	0.000417	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000116	0.000417	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—TYMP—urinary bladder cancer	0.000115	0.000413	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—TYMS—urinary bladder cancer	0.000109	0.000392	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—NCOR1—urinary bladder cancer	0.000108	0.000388	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—GSTM1—urinary bladder cancer	0.000108	0.000388	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—NQO1—urinary bladder cancer	0.000107	0.000384	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	0.000106	0.000382	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000106	0.000382	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	0.000106	0.000381	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—NAT2—urinary bladder cancer	0.000104	0.000373	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—GPX1—urinary bladder cancer	0.000103	0.000371	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—ERCC2—urinary bladder cancer	0.000101	0.000365	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	0.0001	0.000361	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—NAT1—urinary bladder cancer	0.0001	0.000361	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.87e-05	0.000355	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—TYMP—urinary bladder cancer	9.71e-05	0.00035	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	9.56e-05	0.000344	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	9.54e-05	0.000344	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—MTHFR—urinary bladder cancer	9.52e-05	0.000343	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	9.45e-05	0.00034	CbGpPWpGaD
Phenelzine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	9.28e-05	0.000334	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	9.18e-05	0.000331	CbGpPWpGaD
Phenelzine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.15e-05	0.000329	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	9.03e-05	0.000325	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	9.01e-05	0.000325	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	8.96e-05	0.000323	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	8.96e-05	0.000323	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—RRM2—urinary bladder cancer	8.95e-05	0.000322	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—GSTP1—urinary bladder cancer	8.88e-05	0.00032	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.81e-05	0.000317	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	8.8e-05	0.000317	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—NAT2—urinary bladder cancer	8.79e-05	0.000316	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	8.78e-05	0.000316	CbGpPWpGaD
Phenelzine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	8.53e-05	0.000307	CbGpPWpGaD
Phenelzine—MAOA—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	8.52e-05	0.000307	CbGpPWpGaD
Phenelzine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.41e-05	0.000303	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—ENO2—urinary bladder cancer	8.29e-05	0.000299	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—HPGDS—urinary bladder cancer	8.29e-05	0.000299	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	8.27e-05	0.000298	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—TYMS—urinary bladder cancer	8.26e-05	0.000297	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	8.2e-05	0.000295	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—GSTM1—urinary bladder cancer	8.16e-05	0.000294	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—NCOR1—urinary bladder cancer	8.16e-05	0.000294	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—GSTT1—urinary bladder cancer	8.04e-05	0.00029	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—GPX1—urinary bladder cancer	7.82e-05	0.000281	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	7.81e-05	0.000281	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—PPARG—urinary bladder cancer	7.72e-05	0.000278	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—ERCC2—urinary bladder cancer	7.68e-05	0.000276	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	7.61e-05	0.000274	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—RRM2—urinary bladder cancer	7.58e-05	0.000273	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—CREBBP—urinary bladder cancer	7.42e-05	0.000267	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	7.38e-05	0.000266	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—MTHFR—urinary bladder cancer	7.22e-05	0.00026	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—TYMP—urinary bladder cancer	7.04e-05	0.000253	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—ENO2—urinary bladder cancer	7.02e-05	0.000253	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	7.02e-05	0.000253	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	7.02e-05	0.000253	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	6.97e-05	0.000251	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	6.81e-05	0.000245	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	6.79e-05	0.000244	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—NQO1—urinary bladder cancer	6.68e-05	0.000241	CbGpPWpGaD
Phenelzine—MAOA—Neuronal System—HRAS—urinary bladder cancer	6.53e-05	0.000235	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—NAT2—urinary bladder cancer	6.36e-05	0.000229	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	6.35e-05	0.000229	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.1e-05	0.00022	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—TYMP—urinary bladder cancer	6.08e-05	0.000219	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—PTGS2—urinary bladder cancer	6.07e-05	0.000219	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—PPARG—urinary bladder cancer	5.85e-05	0.000211	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.84e-05	0.00021	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	5.68e-05	0.000205	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—NQO1—urinary bladder cancer	5.66e-05	0.000204	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—CREBBP—urinary bladder cancer	5.62e-05	0.000202	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—GSTP1—urinary bladder cancer	5.57e-05	0.000201	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	5.5e-05	0.000198	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	5.49e-05	0.000198	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	5.48e-05	0.000197	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.44e-05	0.000196	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	5.43e-05	0.000195	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.39e-05	0.000194	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.39e-05	0.000194	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—PTEN—urinary bladder cancer	5.3e-05	0.000191	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.21e-05	0.000188	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—TYMS—urinary bladder cancer	5.18e-05	0.000187	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—NCOR1—urinary bladder cancer	5.12e-05	0.000184	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—GSTM1—urinary bladder cancer	5.12e-05	0.000184	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	5.09e-05	0.000183	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	5.09e-05	0.000183	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	5.08e-05	0.000183	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	5.08e-05	0.000183	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—EP300—urinary bladder cancer	5.05e-05	0.000182	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	4.93e-05	0.000178	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.93e-05	0.000177	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	4.92e-05	0.000177	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	4.91e-05	0.000177	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—GPX1—urinary bladder cancer	4.91e-05	0.000177	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—ERCC2—urinary bladder cancer	4.82e-05	0.000173	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	4.75e-05	0.000171	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	4.72e-05	0.00017	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—PTGS2—urinary bladder cancer	4.6e-05	0.000166	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—MTHFR—urinary bladder cancer	4.53e-05	0.000163	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.44e-05	0.00016	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	4.4e-05	0.000158	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	4.4e-05	0.000158	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	4.39e-05	0.000158	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.37e-05	0.000157	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	4.34e-05	0.000156	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	4.34e-05	0.000156	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	4.27e-05	0.000154	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	4.24e-05	0.000153	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.2e-05	0.000151	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.19e-05	0.000151	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	4.16e-05	0.00015	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	4.1e-05	0.000148	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	4.09e-05	0.000147	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.08e-05	0.000147	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	4.08e-05	0.000147	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—PTEN—urinary bladder cancer	4.01e-05	0.000145	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	3.93e-05	0.000141	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	3.93e-05	0.000141	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.9e-05	0.00014	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	3.83e-05	0.000138	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—EP300—urinary bladder cancer	3.83e-05	0.000138	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	3.81e-05	0.000137	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.75e-05	0.000135	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—PPARG—urinary bladder cancer	3.67e-05	0.000132	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	3.54e-05	0.000128	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—CREBBP—urinary bladder cancer	3.53e-05	0.000127	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.44e-05	0.000124	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	3.42e-05	0.000123	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	3.41e-05	0.000123	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.26e-05	0.000118	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	3.18e-05	0.000114	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	3.17e-05	0.000114	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.16e-05	0.000114	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	3.14e-05	0.000113	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	3.14e-05	0.000113	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	3.14e-05	0.000113	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	3.14e-05	0.000113	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	3.11e-05	0.000112	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.07e-05	0.000111	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	3.01e-05	0.000108	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	3e-05	0.000108	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3e-05	0.000108	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	2.99e-05	0.000108	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	2.96e-05	0.000106	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.96e-05	0.000106	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.95e-05	0.000106	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	2.95e-05	0.000106	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—PTGS2—urinary bladder cancer	2.89e-05	0.000104	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.86e-05	0.000103	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	2.78e-05	0.0001	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.77e-05	9.98e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.75e-05	9.9e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.72e-05	9.78e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.72e-05	9.78e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.68e-05	9.64e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.64e-05	9.5e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.6e-05	9.37e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.55e-05	9.2e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.55e-05	9.19e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.55e-05	9.18e-05	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—PTEN—urinary bladder cancer	2.52e-05	9.07e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.45e-05	8.83e-05	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	2.45e-05	8.81e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.42e-05	8.73e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.42e-05	8.73e-05	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—EP300—urinary bladder cancer	2.4e-05	8.65e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.4e-05	8.64e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.36e-05	8.5e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.36e-05	8.5e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.32e-05	8.36e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.29e-05	8.24e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.28e-05	8.21e-05	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.25e-05	8.11e-05	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	2.25e-05	8.09e-05	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.16e-05	7.79e-05	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.16e-05	7.77e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.14e-05	7.72e-05	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	2.13e-05	7.68e-05	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—EP300—urinary bladder cancer	2.03e-05	7.32e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.95e-05	7.01e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.9e-05	6.85e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.87e-05	6.73e-05	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.77e-05	6.38e-05	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.77e-05	6.37e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.74e-05	6.26e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.67e-05	6.01e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.59e-05	5.71e-05	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.55e-05	5.56e-05	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.54e-05	5.55e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.53e-05	5.51e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.48e-05	5.31e-05	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.47e-05	5.31e-05	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.47e-05	5.29e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.46e-05	5.25e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.46e-05	5.25e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.4e-05	5.03e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.37e-05	4.94e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.37e-05	4.92e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.34e-05	4.81e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.29e-05	4.64e-05	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.27e-05	4.59e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.19e-05	4.29e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.14e-05	4.09e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.05e-05	3.76e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1e-05	3.61e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	8.22e-06	2.96e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.17e-06	2.58e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—EP300—urinary bladder cancer	6.84e-06	2.46e-05	CbGpPWpGaD
